8 Most Undervalued Pot Stocks to Buy According to Analysts
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational purposes.
Quest Diagnostics Inc (DGX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,000,665 | $155,353,245 | +430% | 0.18% |
| 2. | Citadel Investment Group Ken Griffin | 748,133 | $116,147,649 | -36% | 0.02% |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 473,061 | $73,442,720 | -40% | 0.61% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 269,107 | $41,778,862 | +68% | 0.07% |
| 5. | AQR Capital Management Cliff Asness | 263,337 | $40,609,219 | +79% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.51 | 4,000 | Officer | 44,222 | 2014-05-05 | Filing | |
| $50.71 | 2,600 | Director | 5,658 | 2014-02-06 | Filing | |
| $50.70 | 2,400 | Director | 3,058 | 2014-02-06 | Filing | |
| $59.34 | 5,000 | Officer, Director | 68,034 | 2012-08-07 | Filing | |
| $56.89 | 20,000 | Officer, Director | 63,034 | 2012-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $163.15 | 32,137 | Officer | 38,478 | 2024-11-29 | Filing | |
| $162.26 | 3,009 | Officer | 70,615 | 2024-11-29 | Filing | |
| $163.13 | 28,300 | Officer | 68,412 | 2024-11-27 | Filing | |
| $162.14 | 4,803 | Officer | 96,712 | 2024-11-27 | Filing | |
| $154.74 | 5,189 | Officer | 34,941 | 2024-11-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,576,201 | $1,871,886,594 | 0.04% | |
| 2. | 10,578,368 | $1,458,545,316 | 0.03% | |
| 3. | 5,330,112 | $734,915,843 | 0.03% | |
| 4. | 3,620,124 | $499,142,720 | 0.34% | |
| 5. | 3,476,628 | $479,357,468 | 0.5% |
News See All
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Third Quarter 2024 conference call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Second Quarter 2024 conference call. At the request of the company, this call is being recorded.
Is Quest Diagnostics Incorporated (DGX) an Undervalued High Growth Stock?
Fiduciary Management Inc. (FMI), an independent money management firm, released its second quarter 2024 investor letter.
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2024 Earnings Call Transcript
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.04, expectations were $1.86.
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14.
Here's What Makes Quest Diagnostics (DGX) a Great Long-Term Investment
Davis Funds, an investment management firm, released its "Davis New York Venture Fund" third quarter 2023 investor letter, a copy of which can be downloaded here.
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Third Quarter 2023 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Second Quarter 2023 Conference Call. At the request of the company, this call is being recorded. [Operator Instructions].
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2023 Earnings Call Transcript
Operator: Hello, and thank you all for standing by. Welcome to the Quest Diagnostics First Quarter 2023 Conference Call. At the request of the company, this call is being recorded.
Billionaire Hedge Funds
